US.CAH · Cardinal Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.4835769280613493,
        "turnoverUsdM": 292.801023899686,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CAH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 226.2542,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5,
      "take_profit_price": 249.984,
      "target_multiplier": 1.9,
      "technical_strength": 1.55,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.967153856122699,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 64.4,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 57.4,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 228.3615,
    "ma50": 233.4146,
    "close": 238.08,
    "prevClose": 237.57,
    "avgVolume20": 1851007,
    "volumeRatio": 0.66,
    "changePercent": 0.21
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.021276604323953396,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 0.6480429765304725,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 1.133727858733635,
      "volat_points": 0,
      "day_range_pct": 0.02612571382622889,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 64.4,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 60,
        "contribution": 3
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 17.6,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58.67,
        "contribution": 17.6
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 57.4,
    "details": [
      "基本面分析總分: 3/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 17.6/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3,
      "資金流": 13.2,
      "市場環境": 10.2,
      "情緒分析": 4,
      "技術信號": 17.6,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.4,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 292.801023899686,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CAH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.84
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 739.38449965,
                "ma50": 725.6844004000002,
                "name": "QQQ",
                "close": 746.039978,
                "points": 2
              },
              "spy": {
                "ma20": 768.8379970499998,
                "ma50": 768.1957967800001,
                "name": "SPY",
                "close": 778.099976,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.4835769280613493,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142639890,
                "url": "https://finnhub.io/api/news?id=2a9b5c4bc94a40076ace620f6e0412366dce644e40182ad35f6f69dfcf6878f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.",
                "category": "company",
                "datetime": 1791234004,
                "headline": "Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know"
              },
              {
                "id": 142628856,
                "url": "https://finnhub.io/api/news?id=e3ffb0f1fe5ae01f9083e2e296562d1a5501b5f31ced31fd008934d7ec94bd70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In October 2026, Cardinal Health announced it had entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, maintaining the current scope of distribution services. This long‑dated extension reinforces the durability of Cardinal Health’s core distribution relationships, underscoring the importance of scale partnerships in its business model. We’ll now explore how the extended CVS distribution agreement through 2032 may...",
                "category": "company",
                "datetime": 1791174359,
                "headline": "How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story"
              },
              {
                "id": 142499515,
                "url": "https://finnhub.io/api/news?id=ace080066fe00e3cab647d5a3270d58d32b923e43edeab3791ffd85545748769",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500’s 22.1% return during that period. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790699042,
                "headline": "Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings?"
              },
              {
                "id": 142426938,
                "url": "https://finnhub.io/api/news?id=d72b2baa60fa042ada0dda42cbc00ed654f90a377216baeb460b47386244165f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.",
                "category": "company",
                "datetime": 1790370003,
                "headline": "Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade"
              },
              {
                "id": 142384850,
                "url": "https://finnhub.io/api/news?id=c6a218804c41c29f7762bb4d4a166056b02b4898ea4ab124a4258ccf2f4c3979",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a strong multi year run, investors are increasingly focused on what its earnings actually justify. Cardinal Health has returned about 378.2% over the past 5 years, which puts real pressure on the current valuation story to be supported by the earnings profile. The...",
                "category": "company",
                "datetime": 1790269947,
                "headline": "Cardinal Health (CAH) Stock Looks About Right At Today’s Price"
              },
              {
                "id": 142344111,
                "url": "https://finnhub.io/api/news?id=ddbb1b005d80edd972afb34b9fb792faf60695dfced9605ca4ba1f91a805d05f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $222.04, marking a -1.64% move from the previous day.",
                "category": "company",
                "datetime": 1790115304,
                "headline": "Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know"
              },
              {
                "id": 142337859,
                "url": "https://finnhub.io/api/news?id=5e90da72b9445f8f269fe769a77eee231cb102829bca91c22fcabee80a02ffe0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?"
              },
              {
                "id": 142337838,
                "url": "https://finnhub.io/api/news?id=6db76a3f8a212cf94262559026cc82388f79f756fb940a1139660d6696c625e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?"
              }
            ],
            "raw_source": [
              {
                "id": 142819117,
                "url": "https://finnhub.io/api/news?id=b7d310c02badcba6b5491cdf01827cd87d65bc4f68e94038d857b7107ee5ec73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.",
                "category": "company",
                "datetime": 1791803463,
                "headline": "3 Momentum  Stocks to Target This Week"
              },
              {
                "id": 142797831,
                "url": "https://finnhub.io/api/news?id=9216952c4c5e90fa2b3d1e936ea6ee1b87f485b130df536bba452535a29d7a4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health (CVS) is expanding its pharmacy-focused format by opening nearly 20 smaller neighborhood locations across the US in 2026, including a new Roxbury site in the Boston area. Recent headlines around CVS Health have mixed signals for investors, with Medicare Advantage star rating setbacks and a legal probe weighing on sentiment, while the extended Cardinal Health distribution deal and a reaffirmed dividend provide a steadier backdrop. Even after a one-day share price decline of 1.87%...",
                "category": "company",
                "datetime": 1791684620,
                "headline": "CVS Health (CVS) Opens New Pharmacy Sites As Undervalued Narrative Holds"
              },
              {
                "id": 142774378,
                "url": "https://finnhub.io/api/news?id=6ecf61a08d4e89e309d2bc77c13f5e7c620f7c06baba3507c179f7718a35d78e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Get a weekly dividend recap for Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates.",
                "category": "company",
                "datetime": 1791584761,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 11"
              },
              {
                "id": 142723435,
                "url": "https://finnhub.io/api/news?id=08bacb4f6c36d927c4722aa7437f7f46dee36fd9755b9cab015cc8d26f7cf7dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health (NYSE:CVS) has extended its long-term pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The renewed contracts keep CVS Health as a major customer for both wholesalers, supporting its nationwide pharmacy and retail operations. Management highlighted that the agreements cover prescription drug distribution across CVS Health's retail pharmacies and other dispensing channels. The extension of CVS Health's Cardinal Health and McKesson distribution...",
                "category": "company",
                "datetime": 1791454308,
                "headline": "What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?"
              },
              {
                "id": 142665841,
                "url": "https://finnhub.io/api/news?id=7684ab149c75a6611241a6e241b1447bfb4abc3df76fac2245282768a6c23163",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.",
                "category": "company",
                "datetime": 1791294240,
                "headline": "Reasons to Retain Cardinal Health Stock in Your Portfolio for Now"
              },
              {
                "id": 142662955,
                "url": "https://finnhub.io/api/news?id=a79264aca14b600f8fd73874c113158161ffe44d0b27110d763f44af3d82f8bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Eli Lilly's revenue surged 44.7% in 2025, but Novo Nordisk trades at less than a quarter of its valuation multiple, a stark contrast that reshapes the risk-reward calculus.",
                "category": "company",
                "datetime": 1791293401,
                "headline": "Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142662991,
                "url": "https://finnhub.io/api/news?id=c2cebee0fa6630ea0ee5e9b180005fb1bd4bc8037ddffd67aeb2c4c0ba81dafa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health raises its Health Care Benefits outlook as stronger core trends, led by Medicare, support margin recovery despite medical cost pressures.",
                "category": "company",
                "datetime": 1791289980,
                "headline": "CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?"
              },
              {
                "id": 142663311,
                "url": "https://finnhub.io/api/news?id=350be1c6b590d42583c8170b02cb9c8b72ab948cea820cf13c0bc283ebf7f1d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 40.7% over the past six months, topping the S&P 500 by 23.9 percentage points.",
                "category": "company",
                "datetime": 1791288514,
                "headline": "1 Healthcare Stock with Exciting Potential and 2 We Find Risky"
              },
              {
                "id": 142639890,
                "url": "https://finnhub.io/api/news?id=2a9b5c4bc94a40076ace620f6e0412366dce644e40182ad35f6f69dfcf6878f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.",
                "category": "company",
                "datetime": 1791234004,
                "headline": "Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know"
              },
              {
                "id": 142807153,
                "url": "https://finnhub.io/api/news?id=e92046e308d4620c73845da54ed92b68656e124fbed6946590a065983126f8a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 117 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
                "category": "company",
                "datetime": 1791219564,
                "headline": "Dollar Tree Upgraded, Kroger Downgraded: Updated Rankings on Top Blue-Chip Stocks"
              },
              {
                "id": 142636803,
                "url": "https://finnhub.io/api/news?id=dffa9ba00a4611b8858f901f1a866fd56d06d2beaa5eeb4456000feed06ec675",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Delray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a CAGR of 4.9% during the forecast period. Market growth is driven by the increasing emphasis on infection prevention and cross-contamination control, rising prevalence of chronic diseases, an aging population, growing surgical volumes, and expanding demand for long-term care, outpatient services, a",
                "category": "company",
                "datetime": 1791210600,
                "headline": "Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™"
              },
              {
                "id": 142628856,
                "url": "https://finnhub.io/api/news?id=e3ffb0f1fe5ae01f9083e2e296562d1a5501b5f31ced31fd008934d7ec94bd70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In October 2026, Cardinal Health announced it had entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, maintaining the current scope of distribution services. This long‑dated extension reinforces the durability of Cardinal Health’s core distribution relationships, underscoring the importance of scale partnerships in its business model. We’ll now explore how the extended CVS distribution agreement through 2032 may...",
                "category": "company",
                "datetime": 1791174359,
                "headline": "How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story"
              },
              {
                "id": 142624185,
                "url": "https://finnhub.io/api/news?id=773d3787e684fba498bba3b49094c209329c0e46fcca5973e7c495eb6d0c1b89",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you prioritize income stability or growth potential.",
                "category": "company",
                "datetime": 1791124497,
                "headline": "Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142590125,
                "url": "https://finnhub.io/api/news?id=aab9006d36a58b02b2253317f1a39f0abf20a3409f003a8d9a70e4e807671336",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "CAH",
                "summary": "Stay tuned for the market movements in the S&P500 index on Friday. Check out the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1790951701,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 142588574,
                "url": "https://finnhub.io/api/news?id=84ccaec2825b0d28abb6caaf6d3fe52e576a7aa1808c568dab8b141291eaad47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Medical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.",
                "category": "company",
                "datetime": 1790944860,
                "headline": "Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex"
              },
              {
                "id": 142563714,
                "url": "https://finnhub.io/api/news?id=e98e6cb8cdda4ddef333d043a63b0f58a5549656408252b35331ef9926a27d67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie boasts stronger revenue growth and free cash flow, while Bristol Myers Squibb trades at half the valuation with nearly double the profit margin.",
                "category": "company",
                "datetime": 1790894462,
                "headline": "AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142562967,
                "url": "https://finnhub.io/api/news?id=9d7bff0be52d529ad903a77d56eecb8aaef835962d84ed7e21814020cb92bdec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Investing.com -- Cardinal Health Inc (NYSE:CAH) shares rose 3.7% in Thursday trading after the company announced an extension of its drug distribution agreement with CVS Health through June 2032.",
                "category": "company",
                "datetime": 1790885537,
                "headline": "Cardinal Health rises on extended CVS distribution deal"
              },
              {
                "id": 142557871,
                "url": "https://finnhub.io/api/news?id=ca08e87cc073b3537b6302b1aec358a9cd9a40e9b1c53e2b993d3d4418c781d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extended agreement will maintain the existing scope of distribution services provided by Cardinal Health to CVS Health.",
                "category": "company",
                "datetime": 1790858503,
                "headline": "Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032"
              },
              {
                "id": 142588192,
                "url": "https://finnhub.io/api/news?id=a5de3a7978cd533cf49a7a5e0e5decbfe12ed24021ec5e06c8d8665b7e74714a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/01/Chandler--Arizona---April-08-2023cvs-Hea.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.",
                "category": "company",
                "datetime": 1790855987,
                "headline": "Cardinal Health, McKesson Double Down on CVS Deals Through 2032"
              },
              {
                "id": 142557889,
                "url": "https://finnhub.io/api/news?id=6aef2f6be077d7cadc16d7f461abb00cb9e3ac60b722a6e258a13f9e2397edee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.",
                "category": "company",
                "datetime": 1790855760,
                "headline": "5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve"
              },
              {
                "id": 142555641,
                "url": "https://finnhub.io/api/news?id=a3e1502d871bcbe56680cad5d7fbab78b10d436546c0ffb25a9b10b239fbb40d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.",
                "category": "company",
                "datetime": 1790851800,
                "headline": "Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health"
              },
              {
                "id": 142555642,
                "url": "https://finnhub.io/api/news?id=83e78399d70d2e9048bbc59653dbbd066a665595ec345dded4fcdfc971e16be8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.",
                "category": "company",
                "datetime": 1790851500,
                "headline": "Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5"
              },
              {
                "id": 142557331,
                "url": "https://finnhub.io/api/news?id=181eabde1818c936b30e2f64f1c7596b6288dec66316bdc0bdd85fcb15ddede9",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) reaffirmed FY2027 Adj EPS of $12.40-$12.60 vs $12.04 analyst estimate.",
                "category": "company",
                "datetime": 1790839562,
                "headline": "Cardinal Health Affirms FY2027 Adj EPS Of $12.40-$12.60 vs $12.04 Est"
              },
              {
                "id": 142557332,
                "url": "https://finnhub.io/api/news?id=da931cbb6650fcaea5d4f69e876f89483afdf8236ea63bf3931ad705f7175288",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal",
                "category": "company",
                "datetime": 1790838000,
                "headline": "Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032"
              },
              {
                "id": 142522612,
                "url": "https://finnhub.io/api/news?id=39c8b0d65d016661fc240daa4dc5d5c622c60cf374cedbb1865d36d02d4b09f9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2233434722/image_2233434722.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. Read more on CAH stock here.",
                "category": "company",
                "datetime": 1790780492,
                "headline": "Cardinal Health: I'm Still Buying After Checking The Numbers"
              },
              {
                "id": 142499515,
                "url": "https://finnhub.io/api/news?id=ace080066fe00e3cab647d5a3270d58d32b923e43edeab3791ffd85545748769",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500’s 22.1% return during that period. This may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1790699042,
                "headline": "Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings?"
              },
              {
                "id": 142426691,
                "url": "https://finnhub.io/api/news?id=68c6d99ecb3945426214e324f0415ce3bfad6b187bddbedeb0207483edb9d72e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie bets on pipeline diversification amid patent cliffs, while J&J's higher profitability masks litigation risks, a choice between growth ambition and defensive stability.",
                "category": "company",
                "datetime": 1790378161,
                "headline": "AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142432371,
                "url": "https://finnhub.io/api/news?id=403589f5a28b768b40e6b9e54ab5a5d2aa8836e772aecee6e6c1fa8830560d81",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.",
                "category": "company",
                "datetime": 1790377479,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 27"
              },
              {
                "id": 142426107,
                "url": "https://finnhub.io/api/news?id=3c443fa180b195a06f52ced8a8b5d4a24a692b809dd175762819f3d8ae4b1d19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories.",
                "category": "company",
                "datetime": 1790371321,
                "headline": "AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?"
              },
              {
                "id": 142426938,
                "url": "https://finnhub.io/api/news?id=d72b2baa60fa042ada0dda42cbc00ed654f90a377216baeb460b47386244165f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.",
                "category": "company",
                "datetime": 1790370003,
                "headline": "Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade"
              },
              {
                "id": 142425604,
                "url": "https://finnhub.io/api/news?id=878962ab226368893bd0e3a112a0136b824ea77667f2813f3b7b015570b4a55b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson (MCK) is back in focus after its share price dipped 1.2%, trailing the broader market, as investors weigh mixed earnings estimates against the company’s raised full-year adjusted EPS guidance and specialty-led healthcare footprint. Recent trading has been choppy for McKesson, with the share price slipping 3.95% over the past 30 days even after a 13.86% 90 day share price return and a 5.58% share price gain year to date. That near term hesitation sits against a much stronger backdrop,...",
                "category": "company",
                "datetime": 1790359848,
                "headline": "McKesson (MCK) Lifted Its Guidance, Is The Stock Still 11% Undervalued?"
              },
              {
                "id": 142386749,
                "url": "https://finnhub.io/api/news?id=a527e44c28e4d2901c54177a49412223ada2e94c09864f8c6483e6026a3335f0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Novo Nordisk trades at a steep discount on earnings and sales, while AbbVie grapples with patent cliffs and pricing pressure, but profitability tells a different story.",
                "category": "company",
                "datetime": 1790284741,
                "headline": "AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142386737,
                "url": "https://finnhub.io/api/news?id=8eb972c08a04133027eb920e3fc3b121b93a21bf2259240dd130d95008f10fd5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie leans on legacy income and portfolio transition, while Eli Lilly rides explosive growth in weight-loss drugs, but at vastly different valuations.",
                "category": "company",
                "datetime": 1790281321,
                "headline": "AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142384850,
                "url": "https://finnhub.io/api/news?id=c6a218804c41c29f7762bb4d4a166056b02b4898ea4ab124a4258ccf2f4c3979",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a strong multi year run, investors are increasingly focused on what its earnings actually justify. Cardinal Health has returned about 378.2% over the past 5 years, which puts real pressure on the current valuation story to be supported by the earnings profile. The...",
                "category": "company",
                "datetime": 1790269947,
                "headline": "Cardinal Health (CAH) Stock Looks About Right At Today’s Price"
              },
              {
                "id": 142384809,
                "url": "https://finnhub.io/api/news?id=0d14123a814a7697551c1b9721cb42f411a5c2f323385dcb61a4efd61c8eba17",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.",
                "category": "company",
                "datetime": 1790264700,
                "headline": "Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?"
              },
              {
                "id": 142356738,
                "url": "https://finnhub.io/api/news?id=21e15ff8939138213840552d1c3bc509a44aadc76ba9d923028b76bcfaa6274f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Profiles 3M, Medline, Cardinal Health, Medtronic and DuPont, covering competitors, segments, regional shares, trends and opportunities. Medical Textile Market Medical Textile Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- \"Medical Textile Market Global Report 2026\" has been added to ResearchAndMarkets.com's offering. Medical Textile Market to Reach $64.28 Billion by 2030 as Healthcare Demand Accelerates The global medical textile market is experiencing exponential growth, supported by rising",
                "category": "company",
                "datetime": 1790160660,
                "headline": "Medical Textile Market Global Report 2026: A $39.53 Billion Revenue Surge to $64.28 Billion by 2030 at 26.9% CAGR, Benchmark 3M, Medline Industries, Cardinal Health,  and DuPont to Secure Market Share"
              },
              {
                "id": 142356184,
                "url": "https://finnhub.io/api/news?id=4ead5a736f279d0cb06e4092bbece1405cc2367363f17bce8f873045bd8a2f86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
                "category": "company",
                "datetime": 1790157422,
                "headline": "2 Large-Cap Stocks with Solid Fundamentals and 1 We Brush Off"
              },
              {
                "id": 142344111,
                "url": "https://finnhub.io/api/news?id=ddbb1b005d80edd972afb34b9fb792faf60695dfced9605ca4ba1f91a805d05f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $222.04, marking a -1.64% move from the previous day.",
                "category": "company",
                "datetime": 1790115304,
                "headline": "Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know"
              },
              {
                "id": 142337859,
                "url": "https://finnhub.io/api/news?id=5e90da72b9445f8f269fe769a77eee231cb102829bca91c22fcabee80a02ffe0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?"
              },
              {
                "id": 142337838,
                "url": "https://finnhub.io/api/news?id=6db76a3f8a212cf94262559026cc82388f79f756fb940a1139660d6696c625e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.",
                "category": "company",
                "datetime": 1790083920,
                "headline": "CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?"
              },
              {
                "id": 142337936,
                "url": "https://finnhub.io/api/news?id=b0fa32704cad543f7f67cf49fe6423570ab5a742158d34eec27f8fc36b83acf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "According to the average brokerage recommendation (ABR), one should invest in Cardinal (CAH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
                "category": "company",
                "datetime": 1790083803,
                "headline": "Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?"
              },
              {
                "id": 142315822,
                "url": "https://finnhub.io/api/news?id=3e59c5a142d490e9f2d3d2ec72f8bffda0c3472f6744f8f7756c20aa1a5b6325",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services capabilities and momentum in its international businesses. Speaking at the Morgan Stanley Global Heal",
                "category": "company",
                "datetime": 1790031728,
                "headline": "Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027"
              },
              {
                "id": 142314917,
                "url": "https://finnhub.io/api/news?id=d6784d87f4a81c3449c9561cd8145247cc7c202846e1a6a72ba888cac161c646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.",
                "category": "company",
                "datetime": 1790006880,
                "headline": "Here's What Might Affect CVS Health's 2026 Financial Outlook"
              },
              {
                "id": 142308858,
                "url": "https://finnhub.io/api/news?id=3bb5b5a455323b2d2625a5ec535d1f0028338bbb38d12411de24647de5bcea27",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens. Chief Executive Offi",
                "category": "company",
                "datetime": 1789984924,
                "headline": "Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference"
              },
              {
                "id": 142275861,
                "url": "https://finnhub.io/api/news?id=95acd1f635a48b51eaf39db8878981fa064cecf96174bc5bb8234798f279d408",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what he described as a “constructive” period. Speaking at the Morgan Stanley Global Healthcare Confere",
                "category": "company",
                "datetime": 1789855317,
                "headline": "Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds"
              },
              {
                "id": 142273012,
                "url": "https://finnhub.io/api/news?id=62e5cf6e2c94a2481ea7397ee2ba4c59fd3c08a88cbda805faa70b35eefba81a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported by double-digit earnings growth across each of its five operating segments, while fiscal 2027 guidance reflects continued growth from a more normalized base. Speaking at a Baird event, Hollar said t",
                "category": "company",
                "datetime": 1789833722,
                "headline": "Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand"
              },
              {
                "id": 142262612,
                "url": "https://finnhub.io/api/news?id=9156ecf7e86c027bc888c338607f18b47e365681f01ac12302bef887f39a6413",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)’s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the strength in the shares in a conversation with his co-host David Faber amidst the turmoil in the AI sector on the back of […]",
                "category": "company",
                "datetime": 1789773304,
                "headline": "Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation – But Is He Right?"
              },
              {
                "id": 142262611,
                "url": "https://finnhub.io/api/news?id=51e65494213bb0400c0349c58f22fe3f21acfa3eb6a430626d35ba8b5d581880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare services and products company Cardinal Health (NYSE:CAH)’s shares are up by more than 10% year-to-date but are down by more than 8% since early September. Cramer discussed the firm’s share price performance in his morning appearance on September 15th and wondered whether the weakness was due to a rotation into AI stocks rather than […]",
                "category": "company",
                "datetime": 1789773213,
                "headline": "Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better"
              },
              {
                "id": 142270760,
                "url": "https://finnhub.io/api/news?id=a8243e144bb0c5f7780d839884fdec3451a4733654b7cc2f6f745ff2d11b9ec2",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1789738514,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 142224899,
                "url": "https://finnhub.io/api/news?id=b569c59d9cf8bcb6aa037605376df33f73169cc9b54ac705db0a869a47c744d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.",
                "category": "company",
                "datetime": 1789650540,
                "headline": "BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability"
              },
              {
                "id": 142198301,
                "url": "https://finnhub.io/api/news?id=5d8969518664096ac716935e597abca1b39eb34fc3063b775fe77eab0320ed67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.",
                "category": "company",
                "datetime": 1789575420,
                "headline": "Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?"
              },
              {
                "id": 142198401,
                "url": "https://finnhub.io/api/news?id=985017d81bf6fe904716bb7385e86080cd8d4c65b304ea898b1013534ac1e4e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health has outperformed the Health Care Services industry over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1789552903,
                "headline": "How Is Cardinal Health's Stock Performance Compared to Other Health Care Services Stocks?"
              },
              {
                "id": 142169748,
                "url": "https://finnhub.io/api/news?id=d2f9a13a78eb72304c5f463faa3ecf4070f7fd750faee6857f080b19b1c6a283",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The latest trading day saw Cardinal Health (CAH) settling at $232.36, representing a -1.08% change from its previous close.",
                "category": "company",
                "datetime": 1789509602,
                "headline": "Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 142168977,
                "url": "https://finnhub.io/api/news?id=eeef09be0801d058676a026cfc0ece83b45be9bc4754500a2ee5909255de3c8e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDTCompany ParticipantsDavid Frost - Vice President of Investor...",
                "category": "company",
                "datetime": 1789495901,
                "headline": "Cardinal Health, Inc. (CAH) Presents at 2026 Global Healthcare Conference Transcript"
              },
              {
                "id": 142139634,
                "url": "https://finnhub.io/api/news?id=1540a5e1ee5d3a30af17d96c7d0383ca0d1e6c84f82509b6e90addf3e796c705",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
                "category": "company",
                "datetime": 1789407570,
                "headline": "2 Cash-Producing Stocks Worth Your Attention and 1 We Ignore"
              },
              {
                "id": 142139308,
                "url": "https://finnhub.io/api/news?id=8f218e6f7b910d123201ac23fb800ce70f363d4a3dd35a78f17158dcc3292a09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.",
                "category": "company",
                "datetime": 1789398055,
                "headline": "AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 142137295,
                "url": "https://finnhub.io/api/news?id=dcc4b288ae6e93f54675969bd802a9ab516ad006a056529faa42c98979a51c3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its North American Pharmaceutical, Oncology & Multispecialty and Prescription Technology Solutions businesses. Speaking at the Morgan Stanl",
                "category": "company",
                "datetime": 1789390938,
                "headline": "McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal"
              },
              {
                "id": 142138504,
                "url": "https://finnhub.io/api/news?id=b8246181bd53be2d72735e7741b6015f211decc5b5e266e14e6028129b26132a",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDTCompany ParticipantsDavid Frost - Vice...",
                "category": "company",
                "datetime": 1789385504,
                "headline": "Cardinal Health, Inc. (CAH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript"
              },
              {
                "id": 142135993,
                "url": "https://finnhub.io/api/news?id=da1e88d3e7f35b8059dfd20fd97ed62f63419a669479637d7a9f61c48ee2f6bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality.",
                "category": "company",
                "datetime": 1789383825,
                "headline": "Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 59,
            "discarded_article_count": 45
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.6,
        "grade": "較差",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.4,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.4,
            "vcp_reason": "站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1733053.3333333333,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1561820,
              "avg_vol_20": 1897780,
              "avg_vol_30": 1733053.3333333333,
              "range_pct_10": 0.10609883143398169,
              "range_pct_20": 0.10609883143398169,
              "range_pct_30": 0.13688671760007798,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9011955777471746,
              "dist_to_20d_high": 0.016035740782123473,
              "down_shrink_days": 2,
              "breakout_level_20d": 241.96001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7750849263838382
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.4835769280613493,
              "turnoverUsdM": 292.801023899686,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CAH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 226.2542,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5,
            "take_profit_price": 249.984,
            "target_multiplier": 1.9,
            "technical_strength": 1.55,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.967153856122699,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 5.9129,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.48
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 115.01
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1619
    },
    "kdj": {
      "d": 73.47,
      "j": 92.89,
      "k": 79.94,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 58.52
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 94843,
      "recentSlope": 162294.3,
      "previousSlope": -566980
    },
    "rsi": 73.51,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 221.589,
      "position": "SAR喺價下",
      "distancePct": 6.93,
      "previousTrend": "上升"
    },
    "ma50": 233.4146,
    "macd": {
      "macd": 1.0374839951052763,
      "trend": "強烈看漲",
      "signal": -0.7551607877204651,
      "histogram": 1.7926447828257415
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 227.3497,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 6
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.66,
      "score": 2,
      "avgVolume": 1851007,
      "currentVolume": 1229843
    },
    "derived": {
      "ma20": 228.3615,
      "ma50": 233.4146,
      "prevClose": 237.57,
      "avgVolume10": 1445514,
      "avgVolume20": 1851007,
      "changePercent": 0.21,
      "avgVolumeForScore": 1851007
    },
    "ma_cross": {
      "ma20": 228.3615,
      "ma50": 233.4146,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 228.202,
      "prevMa50": 233.2536,
      "spreadPct": 2.16,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 216.3457,
      "upper": 240.3773,
      "position": "上半部"
    },
    "rsi_short": 82.34,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.66
    }
  }
}

{
  "close": 238.08,
  "volume": 1229843,
  "changePercent": 0.21
}